首页> 外文期刊>DMW: Deutsche Medizinische Wochenschrift >Secondary osteoporosis - Relevant clinical characteristics in diagnosis and therapy [Sekund?re Osteoporose - Praxisrelevante Besonderheiten bei der Diagnostik und Therapie]
【24h】

Secondary osteoporosis - Relevant clinical characteristics in diagnosis and therapy [Sekund?re Osteoporose - Praxisrelevante Besonderheiten bei der Diagnostik und Therapie]

机译:继发性骨质疏松症-诊断和治疗中的相关临床特征[继发性骨质疏松症-诊断和治疗中与实践相关的特征]

获取原文
获取原文并翻译 | 示例
           

摘要

Osteoporosis is a systemic skeletal disease causing increased fracture risk. According to pathogenesis, primary (70-80%) and secondary osteoporosis (20-30%) are distinguished. Secondary osteoporosis comprises all entities in which osteoporosis is predominantly and causally associated with certain diseases or conditions. The aim of this review article is to put attention to special features in diagnosis, prophylaxis and treatment of secondary osteoporosis in general and to demonstrate some forms of secondary osteoporosis which seem particularly important during clinical practice. The manuscript refers to the guidelines of the DVO 2009 for prevention, diagnosis and therapy of osteoporosis and selective original papers considering the special types of secondary osteoporosis. History, clinical examination and basic laboratory tests are indicative for the diagnosis of secondary osteoporosis. Its clinical presentation is frequently characterized by rapid development and multiple fractures. Therefore, early diagnosis, prophylaxis and causal treatment is decisive. If causal treatment is impossible, risk adaption of bone mineral density (BMD) for osteoporosis specific treatment is essential. Common causes are medications, endocrine, gastrointestinal and hematologic diseases. Glucocorticoid induced osteoporosis, antihormonal therapy (aromatase inhibitor in women with breast cancer, androgen deprivation therapy in men with prostate cancer) and vitamin D deficiency causing secondary hyperparathyroidism are presented in detail. History and basic laboratory testing are decisive to identify possible causes for secondary osteoporosis and to initiate early diagnostic procedures. The risk of severe osteoporosis can be reduced by early and causal treatment or by risk stratified early bone specific medication if causal therapy is impossible.
机译:骨质疏松症是一种全身性骨骼疾病,导致骨折风险增加。根据发病机理,将原发性骨质疏松症(70-80%)和继发性骨质疏松症(20-30%)区分开。继发性骨质疏松包括所有与骨质疏松主要和因果相关的疾病或病症相关的实体。这篇综述文章的目的是将注意力转移到一般继发性骨质疏松症的诊断,预防和治疗中,并证明某些形式的继发性骨质疏松症在临床实践中显得尤为重要。该手稿参考了DVO 2009的预防,诊断和治疗骨质疏松症的指南,以及考虑到继发性骨质疏松症的特殊类型的精选原始论文。病史,临床检查和基本的实验室检查均可以诊断继发性骨质疏松。其临床表现通常以快速发展和多处骨折为特征。因此,早期诊断,预防和因果治疗至关重要。如果不可能进行因果治疗,那么针对骨质疏松症特定治疗的骨矿物质密度(BMD)风险适应至关重要。常见原因是药物,内分泌,胃肠道和血液系统疾病。详细介绍了糖皮质激素诱导的骨质疏松症,抗激素疗法(乳腺癌女性中的芳香化酶抑制剂,前列腺癌男性中的雄激素剥夺疗法)以及引起继发性甲状旁腺功能亢进的维生素D缺乏症。历史和基础实验室检查对于确定继发性骨质疏松症的可能原因并启动早期诊断程序至关重要。严重的骨质疏松症的风险可以通过早期因果治疗来降低,或者如果无法进行因果治疗,则可以通过分层分层的早期骨特异性药物来降低风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号